Fore Capital’s Sotera Health SHC Stock Holding History

Fore Capital’s Portfolio SHC Stock Details SHC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-55,000	Closed	-$1.29M	–	53
2021 Q4	$1.29M	Buy	+55,000	New	+$1.32M	0.44%	30

Other funds holding SHC

Warburg Pincus New York $187M AUM 34% 1-Year Est. Return

GTCR LLC Chicago, Illinois $3.91B AUM 14.64% 1-Year Est. Return

Stockbridge Partners Boston, Massachusetts $4.75B AUM 18.52% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Lazard Asset Management New York $66.1B AUM 33.53% 1-Year Est. Return

ACH

ArrowMark Colorado Holdings Denver, Colorado $2.4B AUM 42.85% 1-Year Est. Return

Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return

Victory Capital Management San Antonio, Texas $178B AUM 37.23% 1-Year Est. Return

Schroder Investment Management Group London, United Kingdom $141B AUM 34.18% 1-Year Est. Return

Fore Capital's SHC Position: Q1 2022 in Review

Fore Capital sold out of Sotera Health (SHC) in Q1 2022, closing a stake of 55,000 shares — an estimated $1.29M sold.

Fore Capital first reported a position in SHC in Q4 2021 and held it in 1 quarter. The position peaked at $1.29M in Q4 2021. 147 funds tracked by Wall St. Rank hold SHC as of Q1 2022.

Fore Capital reported no remaining Sotera Health position as of Q1 2022 after selling out during the quarter.
Fore Capital sold 55,000 Sotera Health shares in Q1 2022, an estimated $1.29M.
Fore Capital first reported a position in Sotera Health in Q4 2021 and held it in 1 quarter.
Fore Capital's Sotera Health position peaked at $1.29M in Q4 2021.
147 funds tracked by Wall St. Rank held Sotera Health as of Q1 2022.

Based on Fore Capital's 13F filing for Q1 2022, filed 11 May 2022.